1. Five-membered iminocyclitol α-glucosidase inhibitors: synthetic, biological screening and in silico studies
- Author
-
Elisabete P. Carreiro, Rui Moreira, Rita C. Guedes, Luis R. Guerreiro, Teresa A.F. Cardote, Ana Teresa Caldeira, Anthony J. Burke, and Luís Fernandes
- Subjects
Pyrrolidines ,Glycoside Hydrolase Inhibitors ,Stereochemistry ,In silico ,Clinical Biochemistry ,Pharmaceutical Science ,Saccharomyces cerevisiae ,Biochemistry ,Molecular Docking Simulation ,Pyrrolidine ,chemistry.chemical_compound ,(3,4)-Dihydroxypyrrolidine ,Drug Discovery ,medicine ,Homology modeling ,Enzyme Inhibitors ,Molecular Biology ,Acarbose ,biology ,Chemistry ,Iminocyclitol ,Organic Chemistry ,a-Glucosidase ,Enantiopure compound ,Active site ,alpha-Glucosidases ,Combinatorial chemistry ,Docking (molecular) ,biology.protein ,Molecular Medicine ,Small molecule inhibitor ,Cyclitols ,medicine.drug ,Protein Binding - Abstract
The design and synthesis of a small library of pyrrolidine iminocyclitol inhibitors with a structural similarity to 1,4-dideoxy-1,4-imino-D-arabitol (DAB-1) is reported. This library was specifically designed to gain a better insight into the mechanism of inhibition of glycosidases by polyhydroxylated pyrrolidines or iminocyclitols. Pyrrolidine-3,4-diol 15a and pyrrolidine-3,4-diol diacetate 15b had emerged as the most potent α-glucosidase inhibitors in the series. Docking studies performed with an homology model of α-glucosidase disclosed binding poses for compounds 15a, 15b, 16a, and 16a' occupying the same region as the NH group of the terminal ring of acarbose and suggest a closer and stronger binding of compound 15a and 15b with the enzyme active site residues. Our studies indicate that 2 or 5-hydroxyl substituents appear to be vital for high inhibitory activity.
- Published
- 2012